<DOC>
	<DOCNO>NCT01077817</DOCNO>
	<brief_summary>This 2-phase retrospective database study , use case-cohort inception ( intention-to-treat ) cohort analyse evaluate association oral treatment osteoporosis risk esophageal cancer woman .</brief_summary>
	<brief_title>Observational Study Incidence Rates Esophageal Cancer Women Taking Medications Prevention Treatment Osteoporosis ( MK-0217A-352 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Cases : Women database age 55 older 1996 2008 diagnosis esophageal cancer Comparator Controls : Each case match woman random subcohort 25,000 year birth case database time diagnosis . Women diagnosis cancer Paget 's Disease receive oral intravenous steroid index date</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>